Skip to content

Johnson & Johnson

US · JNJ #19 by market cap Listed 1970 Quant Rating C 56
275.23 -3.20 -1.15%
Collector offline (last heartbeat: 19226s ago) · 2026-09-04 19:59
Pre-market 275.00 -1.23%
After-hours 276.53 +0.47%
Overnight 278.74 +0.11%
Market cap
663.28B
P/B
7.81
EPS
11.03

Quant Ownership Signal how this is computed

Distributing
  • The number of reporting institutions decreased by 21 in the most recent period (2026/Q3).
  • Total institutional ownership fell 0.1 percentage points.

Institutional ownership

Held by institutions
76.50% -0.11pp
Institutions
5,283 -21
As of
2026/Q3 vs. prior period

Holder types

Mutual Fund62.68%
Public Company4.79%
Private Company3.40%
Government Pension Fund2.04%
Sovereign Wealth Fund1.41%
Hedge Fund0.95%
Family Office/Trust0.50%
Insurance Company0.35%
Government0.12%
Other23.76%

Top holders

HolderStake
BlackRock8.80%
Vanguard Capital Management, LLC7.09%
State Street Global Advisors5.55%
Vanguard Portfolio Management, LLC2.67%
Geode Capital Management, LLC2.45%
Other73.44%

Insiders

27 filings tracked · 1 buys · 6 sells

NameRoleStake
Joaquin Duato Chairperson & CEO 0.01%
Jennifer Taubert Executive VP & Worldwide Chairman of Pharmaceuticals 0.01%
Kathryn Wengel Executive VP and Chief Technical Operations & Risk Officer 0.00%
Joseph Wolk Chief Financial Officer 0.00%
Timothy Schmid Executive VP & Worldwide Chairman of MedTech 0.00%
James Swanson Executive Vice President 0.00%
John Reed Executive Vice President of Pharmaceuticals, R&D 0.00%
Robert Decker Controller & Chief Accounting Officer 0.00%
Vanessa Broadhurst Executive Vice President of Global Corporate Affairs 0.00%
Kristen Mulholland Head of Human Resources of Global Total Rewards 0.00%

Quote time 2026-09-04 19:59:32

For reference only, not investment advice.